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TGFb signaling controls diverse normal devel-
opmental processes and pathogenesis of dis-
eases including cancer and autoimmune and
fibrotic diseases. TGFb responses are generally
mediated through transcriptional functions of
Smads. A key step in TGFb signaling is ligand-
induced phosphorylation of receptor-activated
Smads (R-Smads) catalyzed by the TGFb type I
receptor kinase.However, thepotential of Smad
dephosphorylation as a regulatory mechanism
of TGFb signaling and the identity of Smad-
specific phosphatases remain elusive. Using a
functional genomic approach, we have identi-
fied PPM1A/PP2Ca as a bona fide Smad
phosphatase. PPM1A dephosphorylates and
promotes nuclear export of TGFb-activated
Smad2/3. Ectopic expression of PPM1A abol-
ishes TGFb-induced antiproliferative and tran-
scriptional responses, whereas depletion of
PPM1AenhancesTGFb signaling inmammalian
cells. Smad-antagonizing activity of PPM1A is
also observed during Nodal-dependent early
embryogenesis in zebrafish. This work demon-
strates that PPM1A/PP2Ca, through dephos-
phorylation of Smad2/3, plays a critical role in
terminating TGFb signaling.
INTRODUCTION
Members of the TGFb superfamily activate a broad range
of cellular responses in metazoa, including cell prolifera-tion, differentiation, extracellular matrix (ECM) remodel-
ing, and embryonic development (Whitman and Raftery,
2005). They play key roles in the pathogenesis of cancer
and fibrotic, cardiovascular, and autoimmune diseases
(Akhurst, 2004;Waite and Eng, 2003). Smads are essential
intracellular transducers for TGFb signals (Feng and Der-
ynck, 2005; ten Dijke and Hill, 2004) and also serve as
a point of crosstalk with other signaling pathways (Der-
ynck and Zhang, 2003; Moustakas and Heldin, 2005). In
response to TGFb, receptor-activated Smads (R-Smads)
are phosphorylated in their C-terminal SXS motif by type I
receptors. Phosphorylated R-Smads form a complex with
Smad4 and are transported into the nucleus, where
Smads cooperate with specific DNA binding transcription
factors to regulate gene transcription in a context-depen-
dent manner (Feng and Derynck, 2005).
Signal transduction pathways are often regulated by
dynamic interplay between protein kinases and phospha-
tases. Ligand stimulation results in R-Smad phosphoryla-
tion, inhibition of nuclear export, and thus persistent accu-
mulation of Smad complexes in the nucleus (Schmierer
and Hill, 2005). Recent studies imply that R-Smads may
require dephosphorylation to be exported from the nu-
cleus (Inman et al., 2002b; Schmierer and Hill, 2005; Xu
et al., 2002). Although this implicates the existence of a
Smad-specific phosphatase (or phosphatases), the iden-
tity of the phosphatases responsible for dephosphorylat-
ing the SXS motif remains unknown.
Protein serine/threonine phosphatases (PS/TPs) control
cellular functions through cleavage of phosphate from
phosphorylated serine and threonine residues (pS/Ts) in
proteins. PS/TPs are classified into three structurally dis-
tinct families: PPM, PPP, and FCP/SCP (Cohen, 2003;
Gallego and Virshup, 2005). The PPM family, including
PPM1A/PP2Ca, comprises metal-ion-dependent phos-
phatases that aremostly monomeric.Members of the PPPCell 125, 915–928, June 2, 2006 ª2006 Elsevier Inc. 915
family, including PP1 and PP2A, are oligomeric holo-
enzymes with structurally related catalytic subunits and
distinct regulatory subunits. The FCP/SCP family is repre-
sented by FCP1, a phosphatase that dephosphorylates
the carboxy-terminal domain of RNA polymerase II. In
addition to PS/TPs, dual-specific phosphatases (DUSPs)
also catalyze dephosphorylation of pS/Ts.
To identify the long sought-after Smad phosphatase (or
phosphatases), we took a functional genomic approach to
search for those PS/TPs whose expression reduces SXS
phosphorylation of Smad2/3. Here, we present the bio-
chemical, genetic, and functional evidence that clearly
identify PPM1A/PP2Ca as a bona fide phosphatase that
dephosphorylates the SXSmotif of Smads and terminates
TGFb signaling.
RESULTS
Dephosphorylation of the TGFb Signal Transducers
Smad2 and Smad3
We first studied the kinetics of Smad2/3 phosphorylation.
In immortalized human keratinocyte HaCaT cells, levels of
phosphorylated Smad2/3 (P-Smad2/3) peaked at 1 hr
after TGFb treatment and gradually declined in the pres-
ence of continuous TGFb (Figure 1A). To accurately ana-
lyze the dephosphorylation of Smad2/3, HaCaT cells
were treated with TGFb (2 ng/ml, 30 min) to generate
a pool of P-Smad2/3 and then with TbRI kinase inhibitor
SB431542 to prevent rephosphorylation of dephosphory-
lated Smad2/3 (Inman et al., 2002a) (Figure 1B). The re-
sults showed that prephosphorylated Smad2/3 lasted
for <2 hr in the presence of SB431542 and absence of pro-
teasomal inhibitor MG-132 (Figures 1C and 1D). Addition
of MG-132 (20 mM) slowed down the disappearance of
P-Smad2/3 but did not completely restore the P-Smad2/3
levels (Figures 1C and 1D; see also Figure S1 in the Sup-
plemental Data available with this article online), even
though it effectively prevented SnoN degradation (Fig-
ure S1). This indicates that a protein phosphatase (or
phosphatases), not a proteasome, is primarily responsible
for P-Smad2/3 loss.
We next tested whether accumulation of P-Smad2/3
is sensitive to okadaic acid (OA), an inhibitor widely used
to implicate the involvement of PPP phosphatases in reg-
ulating cellular function (Cohen, 2003; Gallego and
Virshup, 2005). OA treatment increased the level of
P-Smad2/3, while it did not affect total levels of Smad2/3
(Figure 1E; Figure S2A), suggesting an involvement of OA-
sensitive phosphatases in regulating P-Smad2/3 levels.
To precisely determine whether OA-sensitive phospha-
tases directly dephosphorylate P-Smad2/3, we took
advantage of TbRI(T204D), a gain-of-function mutant of
human TGFb type I receptor that constitutively phosphor-
ylates Smad2/3 and thus avoids potential effects of de-
phosphorylation on the receptors. OA did not have any
effects on P-Smad2/3 induced by TbRI(T204D) (Fig-
ure 1F; Figure S2B), suggesting that dephosphorylation
of P-Smad2/3 is controlled by an OA-resistant phospha-916 Cell 125, 915–928, June 2, 2006 ª2006 Elsevier Inc.tase (or phosphatases) at the level upstream of Smad2/3
activation.
Functional Genomic Screen Identifies PPM1A as
a Smad Phosphatase
The hypothetical Smad phosphatase (or phosphatases)
targeting the SXS motif should belong to either the PS/TP
or the DUSP family. In a search to identify Smad phospha-
tase (or phosphatases), we focused on the PS/TP family.
With the availability of human genome databases, we gen-
erated expression plasmids for 39 phosphatases (cata-
lytic subunits), including 14 PPMs, 13 PPPs, 5 FCP/
SCPs, 1 PH-domain phosphatase (PHLPP), 4 DUSPs,
and 2 pyrophosphatases. We then examined the effects
of each phosphatase on the P-Smad2/3 level induced by
constitutively active rat TbRI(T202D) and found that only
PPM1A/PP2Ca potently reduced the level of P-Smad2
accumulation (Table S1). These phosphatases are un-
tagged to ensure no interference with their activities, but
a separate Flag-tagged set of phosphatases were also
made to examine their expression in cells (Figure S3A).
PPM1A clearly reduced the level of P-Smad2/3 induced
by TbRI(T202D) (Figures 2A and 2B) or TGFb1 ligand
(data not shown), whereas other phosphatases such as
PPP1CA/PP1, PPP2CA/PP2A, and DUSP1/MKP1 had no
effect (Figure 2A). PPM2C/PDP1 and PDP2, mammalian
homologs ofDrosophila PDP, which was recently identified
as a Mad phosphatase (Chen et al., 2006), also exhibited
no effects on Smad2 dephosphorylation (Table S1 and
Figure S3B). Immunofluorescence staining also supports
the notion that PPM1A promotes dephosphorylation of
Smad2/3, as less P-Smad2/3 was observed in cells ex-
pressing exogenous PPM1A in HaCaT cells (Figure 2C).
To confirm whether the PPM1A phosphatase activity is
essential for Smad2 dephosphorylation, we generated
two catalytically inactive PPM1A mutants, D239N and
R174G (Jackson et al., 2003). We found both D239N and
R174Gmutants lost the ability to dephosphorylate Smad2
(Figure 2D, lanes 3 and 4).
We next examined the effect of PPM1A on Smad2 de-
phosphorylation in the presence or absence of MG-132.
Results showed that MG-132 treatment did not block
the PPM1A-induced decrease in P-Smad2 level (Fig-
ure 2E, lanes 9–11), suggesting that PPM1A reduces the
level of P-Smad2 independently of the 26S proteasome.
To rule out the possibility that PPM1A activates another
phosphatase in cells that could be the direct Smad phos-
phatase, we carried out a cell-free dephosphorylation
assay. Semisynthetic recombinant phospho-MH2 domain
of Smad2 (P-S2MH2) (Wu et al., 2001) could be effectively
dephosphorylated by recombinant PPM1A (Figure 2F,
lane 2). PPM1A activity required Mg2+, as EDTA abolished
dephosphorylation of P-S2MH2 (Figure 2F, lane 4),
consistent with the property of PPM1A as a metal-ion-
dependent phosphatase (Tamura et al., 2003). PPM1A
failed to dephosphorylate Smad2 in the presence of
only Mn2+ or Ca2+ (Figure 2G). In contrast, nonspecific
bacteriophage l phosphatase had Mn2+-dependent, but
Figure 1. Dynamic Phosphorylation and Dephosphorylation of Smad2/3
(A) Time course of Smad2/3 phosphorylation. HaCaT cells were treated with 2 ng/ml of TGFb1 for the indicated time periods. P-Smad2/3 and total
Smad2/3 were analyzed by Western blotting. Left: Line graph representing three independent experiments. Intensity of P-Smad2/3 relative to total
Smad2/3 from each experiment was quantified by NIH Image software. Values are the mean of at least two independent experiments; error bars
are ± standard deviation of the mean. Right: A representative Western blot.
(B) A schematic representation of treatments designed for (C)–(F).
(C) Analysis of Smad2 dephosphorylation. HaCaT cells were treated with 2 ng/ml of TGFb1 for 30 min, followed by TGFb washout and simultaneous
addition of 5 mM SB431542 and 20 mM MG-132. Graph shows relative P-Smad2 level (over total Smad2) from three independent experiments, with
values and error bars representing mean and standard deviation. The insert is one representative experiment.
(D) Experiments equivalent to (C) analyzing Smad3 dephosphorylation in HaCaT cells.
(E) Effect of okadaic acid (OA) on TGFb-dependent phosphorylation of Smad2/3. HaCaT cells were treated with TGFb1 and SB431542 as in (C); in
a separate group of cells, 5 nM OA was added 3.5 hr before TGFb and continued with TGFb and SB431542 treatment (for a total of 8 hr). Graphical
analysis of relative P-Smad2/3 levels is presented here (line graph) and in Figure S2A. Values are mean of three independent experiments; error bars
are ± standard deviation of the mean.
(F) Effect of OA on TbRI(T204D)-induced phosphorylation of Smad2/3. HaCaT cells were infected with AdTbRI(T204D) adenoviruses at moi of 200.
After 48 hr, cells were treated with 5 mM SB431542. Five nanomolar OA was added 3.5 hr before SB431542 addition and remained with SB431542.
Graphical analysis of relative P-Smad2/3 levels is presented here (line graph) and in Figure S2B. Values and error bars are mean and standard
deviation of three independent experiments.Mg2+-independent, dephosphorylating activity toward
P-Smad2 (Figure 2H). These results suggest that phos-
pho-Smad2 is a direct substrate of Mg2+-dependent
PPM1A.
To further examine the specificity of PPM1A, we tested
whether PPM1A dephosphorylates pS212 in the linker re-
gion of Smad3. The S212 residue is phosphorylated by
Cdk4 (Matsuura et al., 2004). PPM1A failed to dephos-phorylate pS212 (Figure 2I) and other pS/T residues in
Smad3 (data not shown). On the other hand, linker PPase
dephosphorylated pS212, but not the SXSmotif. Thus, the
SXS motif is a direct and specific target for PPM1A.
PPM1A Physically Interacts with Smad2
To test whether PPM1A binds to Smad2, we performed
coimmunoprecipitation experiments. Results showed thatCell 125, 915–928, June 2, 2006 ª2006 Elsevier Inc. 917
Figure 2. PPM1A Dephosphorylates Smad2 and Smad3
(A) Smad2 dephosphorylation by PPM1A. In transfected 293T cells, Flag-Smad2 was anti-Flag immunoprecipitated, and levels of P-Smad2 and total
Smad2 were assessed by Western blotting.
(B) PPM1A dephosphorylates Smad3 in 293T cells.
(C) PPM1A reduces endogenous P-Smad2/3 levels. HaCaT cells were transfected with PPM1A, treated with TGFb (2 ng/ml, 1 hr), and immunostained
using anti-PPM1A (Texas red) and P-Smad2 or P-Smad3 (FITC). Arrow indicates reduced P-Smad2/3 in PPM1A-transfected cells.
(D) Smad2 dephosphorylation requires the catalytic activity of PPM1A.
(E) Smad2 dephosphorylation occurs in the presence of MG-132. Flag-PPM1A or His-PPM1A is as efficient as PPM1A.
(F) PPM1A dephosphorylates P-Smad2 MH2 domain (P-S2MH2). Dephosphorylation of P-S2MH2 required 20 mM Mg2+ (lane 2) and was abolished
by 40 mM EDTA (lane 4). Equal amounts of semisynthetic recombinant P-S2MH2 (100 ng, lanes 1–4) and recombinant PPM1A (100 ng, lanes 2–4)
were loaded.
(G) Smad2 dephosphorylation by PPM1A depends on 20 mM Mg2+ (lane 3), but not 2 mM Mn2+ (lane 4) or 20 mM Ca2+ (lane 5).
(H) Smad2 dephosphorylation by l phosphatase (lPPase).
(I) PPM1A specifically dephosphorylates the SXS motif, but not pS212 of Smad3. Linker phosphatase specifically dephosphorylates pS212, but not
the SXS motif.Flag-PPM1A interacted with HA-Smad2 (Figure 3A,
lane 3). Catalytically inactive mutant D239N also retained
the ability to interact with Smad2, suggesting that the
phosphatase activity is not essential for Smad binding
(Figure 3A, lane 4). Similarly, Smad3 interacted with
PPM1A (Figure S4). Notably, the PPM1A-Smad2 interac-
tion also occurred under physiological conditions, as
TGFb stimulated endogenous PPM1A-Smad2 coimmuno-
precipitation (Figure 3B).
We next examined the interaction of Smad2 mutants
with PPM1A. Smad2 phosphorylation-deficient mutant
2SA and phosphorylation-mimetic mutant 2SD carry Ser-918 Cell 125, 915–928, June 2, 2006 ª2006 Elsevier Inc.to-Ala and Ser-to-Asp substitutions at the SXS motif, re-
spectively. Smad2(V398R) has a defect in its nuclear ex-
port and thus localized in the nucleus (Xu et al., 2002).
Results in Figure 3C show that whereas Smad2 wild-
type and 2SA mutant interacted similarly with PPM1A,
V398R mutant clearly exhibited an increased binding to
PPM1A.
Endogenous PPM1A was primarily localized in the
nucleus regardless of TGFb stimulation as determined
by immunofluorescence (Figure 3D). Nuclear/cytoplasmic
fractionation experiments further confirmed that PPM1A
was present in nuclear fraction (Figure 3E). Nuclear protein
Figure 3. PPM1A Interacts with Smad2
(A) Coimmunoprecipitation of Flag-PPM1A and HA-Smad2 in 293T cells. IP, immunoprecipitation; IB, Western blotting; WCL, whole-cell lysates.
(B) Endogenous PPM1A-Smad2 interaction is TGFb inducible. HaCaT cells were treated with TGFb1 (1 hr), and cell lysates were subjected to IP using
anti-PPM1A (lane 5 and 6) or a control mouse antibody (lane 4).
(C) Smad2(V398R) mutant interacts with PPM1A in 293T cells.
(D) Subcellular colocalization of PPM1A and Smad2 in HaCaT cells. Smad2 and PPM1A proteins were detected by using anti-Smad2 (FITC) and anti-
PPM1A (Texas red) antibodies. DNA was stained using DAPI dye.
(E) PPM1A is primarily localized in the nucleus. Left: HaCaT cells treated with TGFb1 (2 ng/ml for 1 hr) were crosslinked with formaldehyde before
fractionation and Western blotting analysis (Supplemental Data). C, cytoplasmic fraction; N, nuclear fraction. Right: NIH 3T3 cells.
(F) Direct interaction of PPM1A with Smad2/3. Purified recombinant His-PPM1A or His-D239N protein bound to recombinant GST-Smad2 (lanes 4
and 7) or Smad3 (lanes 5 and 8) but not GST alone (lanes 3 and 6) was detected by anti-PPM1A Western blotting.
(G) PPM1A exclusively binds to P-Smad2. Recombinant Smad2 MH2 (aa 241–467), phosphorylated (lane 1) or unphosphorylated (lane 2), bound to
recombinant His-PPM1A protein was detected by Western blotting.lamin A and cytoplasmic protein glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) were used as sample
quality controls (Figure 3E). To examine whether endoge-
nous Smad2 colocalized with PPM1A, PPM1A-stained
HaCaT cells were counterstained with anti-Smad2 anti-
body. As expected, in the absence of TGFb, Smad2
expression was both in the nucleus and cytoplasm, with
a diffuse distribution in the cytoplasm (Figure 3D, upper
left). Following TGFb stimulation, Smad2 became local-
ized exclusively in the nucleus (Figure 3D, lower left).
Staining of PPM1A overlaps with nuclear Smad2, particu-
larly in the presence of TGFb.
To assess direct interaction between PPM1A and
Smad2, we carried out an in vitro binding assay usingpurified recombinant proteins. As shown in Figure 3F,
PPM1A bound to glutathione S-transferase (GST)-Smad2
fusion protein (lanes 4 and 7) but not GST protein alone
(lanes 3 and 6). PPM1A also bound directly to GST-
Smad3 fusion protein (lanes 5 and 8). Both wild-type
and mutant PPM1A bound equally to Smad2 or Smad3.
Furthermore, when assayed in parallel, phosphorylated
Smad2, but not the unphosphorylated form, could bind
to PPM1A (Figure 3G).
PPM1A Regulates Complex Formation and Nuclear
Export of Smad2
To further establish the function of PPM1A in TGFb signal-
ing,we investigated its loss-of-function or gain-of-functionsCell 125, 915–928, June 2, 2006 ª2006 Elsevier Inc. 919
Figure 4. PPM1A Regulates Phosphorylation, Oligomerization, and Nuclear Export of Smads
(A) Specific PPM1A knockdown in 293T cells. Flag-hPPM1A, Flag-tagged human PPM1A; Flag-zPPM1A, Flag-zebrafish PPM1A; h, shPPM1A494
against human PPM1A; m, shmPPM1A494 against mouse PPM1A. The level of P-Smad2 was inversely correlated with that of PPM1A.
(B) Reduced Smad2/3 dephosphorylation in HaCaT-shPPM1A cells. Left: Cells were treated with TGFb and SB431542 and analyzed as described in
Figure 1C. Right: Line graph showing relative levels of P-Smad2/3 over those of total Smad2/3 from three independent clones with two experiments
each, with values and error bars representing the average and standard deviation.
(C) qRT-PCR analysis of PPM1A mRNA in shPPM1A cells. Values and error bars represent mean and standard deviation of two experiments (each
with triplicates).
(D) Stable PPM1A depletion increases Smad2 phosphorylation and association with Smad4. HaCaT-shPPM1A or control cells were treated with
TGFb (2 ng/ml, 1 hr). Nuclear and cytoplasmic fractions (Supplemental Data) were subjected to anti-Smad4 IP and Western blotting.
(E) PPM1A depletion increases Smad2 accumulation in the nucleus. Cells were treated with TGFb for 1 hr and then with SB431542 for 0.5, 1, 2, or 4 hr.
Smad2 was visualized using anti-Smad2 antibody (FITC). DAPI (DNA staining) and merge are indicated.
(F) Wild-type PPM1A (WT), but not D239 mutant (DN), causes Smad2/3-Smad4 dissociation.
(G) PPM1A promotes nuclear export of Smad2. An MS2-based quantitative analysis of nuclear transport assay system was used (Supplemental
Data). Values and error bars represent mean and standard deviation of three experiments.effects on Smad phosphorylation, oligomerization, and
nuclear export. We first used short hairpin RNAs (shRNAs)
to knock down the expression of PPM1A (shPPM1A). Two
of three shPPM1As could efficiently and specifically
knock down the expression of PPM1A in transiently trans-
fected 293T cells (Figure S5A). As shown in Figure 4A,
the P-Smad2 level induced by TGFb was diminished in
the presence of human PPM1A (lane 2) but was restored
by coexpression of shPPM1A494, correlating with the
depleted level of PPM1A (lane 3). Similar results were
observed on Smad3 dephosphorylation (Figure S5B).
As a control, shmPPM1A494 targeted to the correspond-920 Cell 125, 915–928, June 2, 2006 ª2006 Elsevier Inc.ing mouse PPM1A sequence (with 3 bp mismatch be-
tween the human and mouse target sequences) did not
suppress the expression of human PPM1A and thus did
not restore P-Smad2 accumulation (Figure 4A, lane 4).
More importantly, zebrafish PPM1A (zPPM1A), which
displays 75% sequence identity to human PPM1A (Fig-
ure S6), was capable of dephosphorylating P-Smad2
(Figure 4A, lane 5) and P-Smad3 (Figure S5) and retained
theability todephosphorylateP-Smad2/3even in thepres-
ence of shPPM1A494 (Figure 4A, lane 6; Figure S5), indi-
cating the specificity of shPPM1A494 toward human
PPM1A.
We also established HaCaT cell lines stably expressing
shPPM1A. In these cells, which exhibited an at least
80% reduction in PPM1A protein level (Figure 4B, lanes
7–12) or mRNA level (Figure 4C), levels of P-Smad2/3
(relative to total levels of Smad2/3) in response to TGFb
were significantly increased (Figure 4B, lane 8). In the
presence of SB431542 that blocks rephosphorylation of
Smad2/3 by inhibiting TbRI, the increased P-Smad2/3
levels in shPPM1Acells remained higher than those in con-
trol cells at the same time point (Figure 4B), suggesting
a loss of dephosphorylation.
Since PPM1A is a phosphatase toward P-Smad2/3 in
the nucleus (Figure 3), we anticipate that depletion of
PPM1A increases the levels of P-Smad2/3 and subse-
quently their association with Smad4 in the nucleus.
Nuclear and cytoplasmic fractions were obtained from
both shPPM1A and control cells with or without TGFb
treatment. In control cells, TGFb clearly induced Smad2/3
to shift from cytoplasm to the nucleus, and P-Smad2/3
were only observed in TGFb-treated nuclear fractions
(Figure 4D, lanes 1–4). Depletion of PPM1A further in-
creased the cytoplasmic-to-nuclear shift of Smad2/3. As
a result, the level of P-Smad2/3 was higher, and conse-
quently, a higher level of Smad2-Smad4 complex accu-
mulated in the nucleus in shPPM1A cells (Figure 4D, lanes
5–8). Immunofluorescence also confirmed that shPPM1A
cells had a higher level of Smad2 in the nucleus in the ab-
sence of TGFb stimulation (Figure 4E). Notably, whereas
SB431542 rapidly reduced nuclear accumulation of
Smad2 in control cells, knockdown of PPM1A appeared
to maintain a high level of nuclear Smad2 even in the pres-
ence of SB432542 (Figure 4E).
Conversely, overexpression of PPM1A abolished TGFb-
induced complex formation of Smad2-Smad4 (Figure 4F,
compares lanes 4 and 5) and Smad3-Smad4 (compare
lanes 8 and 9). The phosphatase-dead D239N mutant
had no effects on complex formation between Smad2/3
and Smad4 (lanes 6 and 10). Considering that PPM1A
dephosphorylates Smad2/3 in the nucleus, these results
indicate that PPM1A causes dissociation of dephosphory-
lated Smad2/3 from Smad4.
We next sought to determine whether PPM1A regulates
nuclear export of Smad2 since previous studies demon-
strated that dephosphorylated Smad2 cycles back to the
cytoplasm (Inman et al., 2002b; Xu et al., 2002). In this
regard, we used a highly sensitive nuclear-export reporter
assay (Coburn et al., 2001; Cullen, 2004) that was previ-
ously used to identify residues essential for Smad2 nu-
clear export (Xu et al., 2002) (Figure S7). As controls,
HIV RNA export factor Rev, but not its mutant M10,
showed clear nuclear-export activity (Coburn et al.,
2001; Cullen, 2004; Figure 4G). As expected, Smad2
also exhibited nuclear-export activity, which is inhibited
by FAST-1 (Xu et al., 2002; Figure 4G). We found that
PPM1A further increased nuclear-export activity of
Smad2, but not that of Rev, whereas the phosphatase-
deadmutant R174Gdominant-negatively inhibitedSmad2
nuclear export. Thus, consistent with its role in dephos-phorylating Smad2/3, PPM1A promotes Smad2 nuclear
export.
Loss of PPM1A Expression Causes Hyperactive
Antiproliferative and Transcriptional Responses
to TGFb
Having established the role of PPM1A in Smad2/3 de-
phosphorylation, we attempted to determine whether
PPM1A-mediated Smad2/3 dephosphorylation controls
the strength of TGFb responses. We first assessed the
antiproliferative effects of TGFb by [3H]thymidine incorpo-
ration in PPM1A-depleted stable cells (shPPM1A cells) in
comparison to control cells. Control cells exhibited a nor-
mal TGFb dosage-dependent inhibitory response on DNA
synthesis in the presence of 10% fetal bovine serum, as
these cells remained proliferative at low doses (0.05 and
0.1 ng/ml) of TGFb, but their proliferation was inhibited
to 40% at a higher dose of TGFb (5 ng/ml) (Figure 5A).
Knockdown of PPM1A rendered cells more sensitive
to TGFb-induced growth inhibition (Figure 5A). Thus,
PPM1A-mediated dephosphorylation limits the ability of
TGFb to exert its inhibitory response in DNA synthesis.
TGFb-induced growth arrest is partly through upregula-
tion of the CDK inhibitors p15 (Hannon and Beach, 1994)
and p21 (Datto et al., 1995) as well as downregulation of
c-myc (Alexandrow et al., 1995). Smad2/3 mediate the
transcriptional regulation of p15 (Feng et al., 2000), p21
(Pardali et al., 2000; Seoane et al., 2004), and c-myc
(Chen et al., 2002; Frederick et al., 2004). To characterize
the effect of PPM1A knockdown on TGFb transcriptional
responses, we examined the levels of p15, p21, and
c-myc mRNAs in shPPM1A cells. TGFb induced higher
levels of both p15 (Figure 5B) and p21mRNAs (Figure 5D),
consistent with the increased sensitivity of shPPM1A
cells to TGFb (Figure 5A). Depletion of PPM1A also in-
creased the basal levels of both p15 and p21mRNAs (Fig-
ures 5B and 5D), perhaps independently of non-Smad
pathways as inhibitors of p38, PI3K, and GSK3 did not
reduce the high basal level of p21 mRNA (Figure 5E).
Increased p15 and p21 expression correlated with
increased promoter activities of these genes (Figures
5C and 5F). Simultaneous knockdown of Smad2 and
Smad3 abolished TGFb-induced p21 promoter activity
(Figure 5F). With regard to c-myc expression, we found
that depletion of PPM1A accelerated TGFb-mediated re-
pression of c-myc even though shPPM1A cells exhibited
a higher basal level of c-myc mRNA. TGFb treatment at
8 hr caused a 90% decrease in the c-myc mRNA level,
in comparison to only 70% decrease in control cells
(Figure 5G). Thus, sustained activation of the Smad path-
way leads to enhanced p15/p21 induction and c-myc
repression in response to TGFb.
In addition to its potent growth-inhibitory response,
TGFb strongly stimulates ECM production by inducing ex-
pression of such genes as plasminogen activator inhibitor
type 1 (PAI-1) and fibronectin (FN1) through a Smad-
dependent mechanism (Datta et al., 2000; Dennler et al.,
1998; Itoh et al., 2003; Stroschein et al., 1999). WeCell 125, 915–928, June 2, 2006 ª2006 Elsevier Inc. 921
Figure 5. Loss of PPM1A Promotes TGFb Signaling
(A) Loss of PPM1A enhances TGFb antiproliferative response in HaCaT cells. DNA synthesis in shPPM1A cells and control cells was determined by
[3H]thymidine incorporation assay. Values and error bars represent the mean and standard deviation of two experiments.
(B) Enhanced expression of p15 in shPPM1A cells as assessed by qRT-PCR. Values and error bars represent the mean and standard deviation of two
experiments (likewise for all qRT-PCR analyses below).
(C) Increased p15 promoter activity in shPPM1A cells. Values and error bars represent the mean and standard deviation of at least three experiments
(likewise for all reporter analyses below).
(D) qRT-PCR analysis of p21 in HaCaT cells.
(E) Inhibitors of p38, PI3K, and GSK3 have no or minimal effect on the basal level of p21mRNA. Cells were treated with inhibitors of p38 kinase (10 mM
SB202190), PI3K (10 mM LY294002), and GSK3 (2 mM SB216763) for 3 hr before TGFb treatment and RNA analysis.
(F) Smad2/3 mediate increased levels of both basal and inducible p21 promoter activity. pSRG-shS2/3 simultaneously express shSmad2 and
shSmad3. pSRG is an empty vector.
(G) qRT-PCR analysis of c-myc in HaCaT cells.
(H) qRT-PCR analysis of PAI-1 in HaCaT cells.
(I) Increased PAI-1 promoter activity in shPPM1A cells.
(J) qRT-PCR analysis of FN in HaCaT cells.
(K) PPM1A does not influence GAPDH mRNA level.observed that TGFb-induced transcription of these two
genes displays distinct patterns in HaCaT cells. In control
cells, PAI-1 mRNA increased by 23-fold after 4 hr of
TGFb treatment, reached 25-fold after another 4 hr, but
declined to6-fold after 24 hr of TGFb stimulation, indicat-
ing the termination of TGFb signals (Figure 5H). Although
it exhibited a minimal effect on PAI-1 expression at 4 and
8 hr, knockdown of PPM1A induced an even higher
level of PAI-1 mRNA after prolonged TGFb treatment,
reaching a >40-fold induction after 24 hr of TGFb stimula-922 Cell 125, 915–928, June 2, 2006 ª2006 Elsevier Inc.tion (Figure 5H). The PAI-1 promoter activity was corre-
spondingly increased in shPPM1A cells (Figure 5I). In the
case of FN, we observed that TGFb gradually induced
FN mRNA, which reached a 7-fold increase after 24 hr
in control cells (Figure 5J). In shPPM1A cells, the FN
induction trend remained similar, but the overall TGFb-me-
diated induction was more profound. At 24 hr, the FN
mRNA increased by 12-fold (Figure 5J). As a control,
GAPDHmRNA remained unchanged after PPM1A knock-
down (Figure 5K). These data support the notion that
Figure 6. Inducible Expression of PPM1A Causes TGFb Resistance
(A) Reduced Smad2/3 phosphorylation in Mv1Lu cells with inducible expression of PPM1A. Mv1Lu-tet-off cells stably harboring Flag-PPM1A were
grownwith (+) or without () 10 ng/ml of doxycycline (Dox). Left: Induced expression of Flag-PPM1A (lanes 7–12). Cells were pretreated with TGFb for
30 min (lanes 2 and 8) and then SB431542 for the indicated time periods (lanes 3–6 and 9–12). Levels of P-Smads, total Smads, and PPM1A
were detected by Western blotting. Right: Line graph representing data from two stable clones with two experiments each, with values and error
bars representing mean and standard deviation.
(B) PPM1A causes partial TGFb resistance. Mv1Lu-PPM1A cells were cultured ±Dox, treated with various doses of TGFb, and subjected to
[3H]thymidine incorporation to analyze DNA synthesis.
(C) PPM1A blocks the TGFb antiproliferative response. Mv1Lu-PPM1A cells, cultured ±Dox and treated ±TGFb (0.2 ng/ml, 12 hr), were stained for
PCNA (Zymed). PCNA-positive (black) and -negative (light gray) cells were counted and plotted.
(D) A representative field of PCNA staining as in (C).
(E) qRT-PCR analysis of PAI-1 in Mv1Lu cells. Values and error bars represent the mean and standard deviation of two experiments.
(F) PPM1A inhibits PAI-1 promoter activity. Left: Stable Mv1Lu cells were transfected with p800-luc and grown with (+) or without () Dox. Right:
HaCaT cells were transiently transfected with p800-luc and PPM1A expression plasmids. Values and error bars represent the mean and standard
deviation of at least three experiments.depletion of PPM1A expression enhances global TGFb
signaling.
Inducible Expression of PPM1A Decreases
TGFb Responses
Having established that PPM1A knockdown results in
hyperactive TGFb signaling, we then tested whether over-
expression of PPM1A leads to reduced TGFb responses.
To this end, we generated stable Mv1Lu cell lines that
express PPM1A in a tetracycline-regulatable system (tet-
off). We selected clones with increased expression of
PPM1A at a level only comparable to that of endogenous
PPM1A after removal of doxycycline (Figure 6A, lanes 7–
12). This low-level expression of PPM1A sufficed to re-
duce the levels of P-Smad2/3 induced by TGFb (Figure 6A,
lane 8). On the contrary, increased expression of PPM1A
(Dox) did not exert any effects on TGFb-induced activa-tion of non-Smad pathways in Mv1Lu cells (Figure S8A) or
NIH 3T3 cells (Figure S8B).
The growth-inhibitory effect of TGFb was evaluated by
[3H]thymidine incorporation in the Mv1Lu tet-off cells. In
the presence of Dox (+Dox), Mv1Lu cells exhibited a
potent TGFb-dependent inhibition on DNA synthesis,
achieving a 90% inhibition at 0.5 ng/ml or higher doses of
TGFb (Figure 6B). Notably, expression of PPM1A (Dox)
significantly reducedTGFb-induced inhibitiononDNAsyn-
thesis, particularly at low dosages of TGFb. At 0.05 ng/ml
of TGFb, cells expressing PPM1A were completely refrac-
tory to TGFb, whereas control cells exhibited 30% inhibi-
tion on DNA synthesis (Figure 6B). PPM1A’s effect on the
TGFb growth-inhibitory response was also demonstrated
by PCNA (proliferating cell nuclear antigen) staining. With-
out exogenous PPM1A expression (+Dox), PCNA-positive
cells decreased from 92% to 42% in response to TGFb,Cell 125, 915–928, June 2, 2006 ª2006 Elsevier Inc. 923
Figure 7. Function of PPM1A in Zebrafish Embryos
(A) Lateral view of live embryos at 24 hpf (hours postfertilization). Right: Embryo injected with 300 pg of ppm1amRNA. Eyes are indicated by arrow-
head.
(B) Ventral view of embryos shown in (A). Note that eyes (arrowhead) were fused in the ppm1a-injected embryo.
(C–E) Embryos injected with 400 pg of ppm1amRNA resulted in decreased gsc expression in the shield (C), loss of gsc expression in the prechordal
plate (D), and mislocalization of lefty2 expression domain (heart) in the right at 24 hpf (E). Embryos were dorsal views with the animal pole at the top
(C and D) or ventral views of heads (E).
(F–M) Embryos injected with 5 ng of S2MH2 protein exhibited head enlargement (G and K) and/or tail loss (G and L) at 24 hpf. Coinjection with 400 pg
of ppm1a mRNA allowed a majority of embryos to develop an abnormal tail at 24 hpf (H and M). Statistical data are shown in (I).
(N–Q) gsc expression at the shield stage. Dorsal views of embryos injected with 5 ng of S2MH2 and/or 400 pg of ppm1amRNA are shown. Note that
the gsc-inducing effect of S2MH2 was counteracted by ppm1a.924 Cell 125, 915–928, June 2, 2006 ª2006 Elsevier Inc.
whereas PPM1A expression (Dox) blocked TGFb-de-
pendent inhibition on PCNA expression (Figures 6C and
6D). These results strongly suggest that inducible expres-
sion of PPM1A renders cells resistant to TGFb antiprolifer-
ative effects.
We also determined whether increased expression of
PPM1A inhibited Smad-dependent gene transcription in
Mv1Lu cells. Expression of mink PAI-1 mRNA was in-
duced by TGFb in the presence of Dox, but this induction
was markedly compromised after Dox withdrawal, sug-
gesting that PPM1A inhibits TGFb-induced PAI-1 tran-
scription (Figure 6E). The PPM1A suppressive effect on
endogenous PAI-1 expression correlated with decreased
PAI-1 promoter activity in these cells (Figure 6F), which
also coincides with loss of P-Smad2 (Figure S9). In addi-
tion, PPM1A blocked TGFb-induced PAI-1 promoter
activity in HaCaT cells (Figure 6F). Interestingly, D239N
and R174G mutants appeared to enhance TGFb-induced
PAI-1 transcription (Figure 6F) as well as other gene re-
sponses (Figure S10), suggesting a dominant-negative ef-
fect of these mutants on TGFb transcriptional responses.
PPM1A Antagonizes Dorsalizing Activity of TGFb/
Nodal Signaling In Vivo
TGFb signaling pathways are highly conserved during
evolution. We hypothesized that PPM1A-mediated de-
phosphorylation of Smad2/3 inhibits Nodal signaling dur-
ing zebrafish early embryogenesis. Zebrafish PPM1A,
which has 75% amino acid sequence identity to human
PPM1A (Figure S6), displayed strong activity toward
dephosphorylating P-Smad2 (Figure 4A) and P-Smad3
(Figure S5). Zebrafish PPM1A was expressed from the
one-cell stage through 24 hr postfertilization (hpf) in a ubiq-
uitousmanner (Figure S11A). When injected with zebrafish
PPM1AmRNA, 25.9% of embryos showed partial or com-
plete fusion of eyes and thinner posterior notochord (Fig-
ures 7A and 7B). Since eye fusion is associated with loss
of anterior prechordal plate mesoderm and is often seen
in zebrafish mutant embryos defective in Nodal signal-
ing pathway (Schier, 2003), we examined expression of
the Nodal target gene goosecoid (gsc), which occurs in
the embryonic shield at the onset of gastrulation and in the
prechordal plate by the end of gastrulation (Schulte-
Merker et al., 1994). Overexpression of PPM1A reduced
gsc expression at the shield stage (Figure 7C) and further
decreased or abolished gsc expression at the bud stage
(Figure 7D), suggesting that PPM1A negatively regulates
Nodal signaling and inhibits dorsal mesoderm develop-
ment. Nodal signaling is also essential for establishment
of vertebrate left-right asymmetry (Hamada et al., 2002).
We noticed that lefty2 expression in the heart at 24 hpf
switched to the middle or right in 27.3% of embryos in-
jected with PPM1A mRNA (Figure 7E), further supportinga role of PPM1A in blocking Nodal-mediated regulation
of left-right asymmetry.
Nextweanalyzedgenetic interactionsbetweenSmad2/3
and PPM1A in zebrafish embryos. Embryos (93.9%)
injected with recombinant MH2 domain of human Smad2
(i.e., S2MH2) were severely dorsalized, as manifested by
an enlarged head and absence of the tail (Figures 7G,
7K, and 7L). When PPM1A mRNA was coinjected with
the same amount of S2MH2, over 60% of embryos devel-
oped a tail, albeit with some abnormalities (Figures 7H, 7I,
and 7M). We did not observe eye fusion in any coinjected
embryos (Figure 7M). S2MH2-induced gsc expression
was inhibited by overexpression of PPM1A (Figures 7N–
7W). In addition, dorsalizing effects causedbyoverexpres-
sion of zebrafish Smad3b were also inhibited by PPM1A
overexpression (Figures S11B–S11I). Taken together,
these data suggest that PPM1A antagonizes dorsalizing
activity of Smad2/3.
DISCUSSION
Stringent control of TGFb signaling through regulation of
Smads is critical for normal cellular responses. As the
SXS motif’s phosphorylation is essential in Smad activa-
tion, its dephosphorylation conversely serves as an impor-
tant countermechanism for terminating Smad signaling.
Previous studies have indicated that dephosphorylation
allows disassembly of the Smad activator complex and
subsequent nuclear export of R-Smads (Inman et al.,
2002b; Xu et al., 2002). Here we present several lines of
evidence demonstrating PPM1A-mediated dephosphory-
lation of Smad2/3, which provides some insights into how
TGFb signaling is terminated. First, of 39 phosphatases
screened, only PPM1A dephosphorylates P-Smad2/3.
Second, purified PPM1A is capable of dephosphorylating
recombinant phospho-Smad2 MH2 in a cell-free assay.
Third, PPM1A physically interacts with Smad2. Signifi-
cantly, PPM1A exhibits a strong affinity for P-Smad2.
Considering that there is no substantial pool of P-
Smad2/3 in the cytoplasm (Schmierer and Hill, 2005),
our data lend further support to the notion that PPM1A
dephosphorylates P-Smad2/3 in the nucleus. Fourth, in-
creased Smad dephosphorylation by PPM1A renders
highly TGFb-sensitive Mv1Lu cells refractory to TGFb.
Fifth, knockdown of endogenous PPM1A sensitizes cells
to respond to TGFb. On the contrary, PPM1A has no effect
on activation of TGFb-induced non-Smad pathways (Fig-
ure S8) and contact-inhibition-induced p27 expression
(Figure S12). Lastly, ectopic expression of PPM1A in
zebrafish phenocopies Nodal-deficient mutant embryos
and inhibits Smad2/3-induced dorsalization, suggesting
a role of PPM1A in regulating Smad2/3-mediated Nodal
or Nodal-like signals during development of vertebrate
embryos. Thus, we propose that PPM1A terminates(R–U) gsc expression at the bud stage. Experiments were done similarly to in (N)–(Q).
(V and W) Statistical data for gsc expression as shown in (N)–(U). Embryos were classified, based on degree of change in gsc expression, into four
categories: normal, reduction, loss (loss in the prechordal plate), and expansion.Cell 125, 915–928, June 2, 2006 ª2006 Elsevier Inc. 925
TGFb signaling through dephosphorylation of P-Smad2/3,
dissociation of the Smad complex, and subsequent
nuclear export of Smad2/3 (Figure S16).
An interesting question is, how selective is PPM1A to-
ward Smad dephosphorylation? While PPM1A dephos-
phorylates Smad2/3 (Figure 2), PPM1A also appears to
be responsible for Smad1/5/8 SXS dephosphorylation
(Figure S14 and data not shown). Unlike Smad2/3, which
are only targeted by PPM1A (of 39 phosphatases
screened), Smad1 can be dephosphorylated by several
other phosphatases besides PPM1A (data not shown),
displaying certain specificity and complexity. On the same
Smad2/3molecules, PPM1A exhibits remarkable selectiv-
ity toward phosphoserine residues, as it dephosphory-
lates the SXS motif, but not pS/T sites in the linker region
(Figure 2I and data not shown). In addition, PPM1A
does not influence TbRI activation upstream of Smad2/3
(Figure S13B).
Although PPM1A was first identified nearly 20 years
ago, only a limited number of substrates have been re-
ported (Tamura et al., 2003). PPM1A specifically interacts
with and dephosphorylates the phosphorylated sub-
strates, including p38 kinase (Takekawa et al., 1998),
Cdk2 (Cheng et al., 1999), phosphatidylinositol 3-kinase
(PI3K) (Yoshizaki et al., 2004), and Axin (Strovel et al.,
2000). Our study extends this substrate list by adding
Smad2andSmad3.Notably, p38,PI3K, andGSK3kinases
represent non-Smad targets activated by TGFb. However,
PPM1A does not influence TGFb-mediated activation of
these kinases (Figure S8), nor do these kinases mediate
PPM1A-mediated inhibition of Smad signaling (Figure 5E
and data not shown).
At present, it is unclear how PPM1A is regulated in cells.
TGFb seems to have no effect on the subcellular localiza-
tion (Figure 3D), expression (Figure 4C), and activity of
PPM1A (Figure S15). A recent study reports that G protein
a2 inhibitory subunit (Gai2) prevents Smad2 dephosphor-
ylation in T cells; it is conceivable that PPM1A is the phos-
phatase inhibited by Gai2 (Wu et al., 2005). It will be of
great interest to examine how activity or subcellular local-
ization of PPM1A is regulated to control TGFb signaling
under physiological and pathophysiological conditions.
Despite biochemical and functional evidence demon-
strating specific dephosphorylating effects of PPM1A on
Smad2/3, our results do not exclude involvement of addi-
tional phosphatases in Smad dephosphorylation. In our
study, only 4 of 62 DUSPs have been analyzed. In addi-
tion, screening all PS/TPs through transient expression
is limited by the possibility that, in the case of polymeric
phosphatases, expression of the catalytic subunit may
not suffice to achieve detectable phosphatase activity. A
previous study reports that activity of a RARa-dependent
and okadaic-acid-sensitive phosphatase limits the levels
of P-Smad2/3 induced by TGFb (Cao et al., 2003), per-
haps through dephosphorylation toward molecules up-
stream of Smads such as TGFb receptors (Figures 1E
and 1F). Indeed, previous studies have revealed regula-
tory roles of the PPP-family phosphatases at the receptor926 Cell 125, 915–928, June 2, 2006 ª2006 Elsevier Inc.level (Bennett and Alphey, 2002; Griswold-Prenner et al.,
1998; Shi et al., 2004). Nonetheless, further detailed inves-
tigation is needed to determine whether additional phos-
phatases can directly target the SXS motif of Smad2/3
as well as other R-Smads.
While C-terminal SXS phosphorylation by the type I re-
ceptor is the key event in Smad activation, the linker re-
gion of Smads, which joins the MH1 and MH2 domains,
has also emerged as an important regulatory platform.
The S/T-rich linker of R-Smads is phosphorylated by a
number of protein kinases, including MAPKs (e.g., ERK,
JNK, and p38 kinases), CDKs, and other intracellular
kinases (Feng and Derynck, 2005). Using a similar func-
tional genomic method described in this study, we identi-
fied phosphatases that dephosphorylate specific sites in
the linker of Smad3 (Figure 2I and unpublished data).
Therefore, we anticipate that PPM1A, linker phospha-
tases, and phosphatases for receptors together fine tune
the strength and duration of Smad signaling.
In conclusion, PPM1A is a bona fide phosphatase
that directly dephosphorylates the critical SXS motif of
R-Smads. PPM1A limits the duration of Smad2/3 in their
activated states. Since loss of TGFb responses through
hereditary mutations, somatic mutations, and aberrant
regulationof signalingcomponents hasbeen linked tocan-
cers and genetic diseases (Akhurst, 2004; Roberts and
Wakefield, 2003; Waite and Eng, 2003), our results could
also have important clinical implication. In this regard, on
the basis of its key role in antagonizing TGFb signaling,
PPM1A may represent an important target for potential
therapeutic intervention in cancers and other diseases.
EXPERIMENTAL PROCEDURES
Construction of Human PS/TP cDNA Expression Library
Full-length cDNAs were synthesized from total RNAs of HaCaT cells.
High-fidelity PCR was used to amplify coding regions of known or pu-
tative PS/TPs (only the catalytic subunit if polymeric) encoded by the
human genome, which was then cloned into CMV-driven expression
vector pRK5 (Genentech). Experimental details on PCR conditions and
primer sequences of each phosphatase are in the Supplemental Data.
Expression Plasmids
Expression plasmids for epitope-tagged Smads were described previ-
ously (Feng et al., 2002). Mouse PPM1A, zebrafish PPM1A, and human
PPM1Awith D239N or R174G substitutions were obtained by PCR and
cloned into pRK5F.
To construct shRNA plasmids, a derivative of pSUPER-retro vector
called pSRG was created. We made the following shRNA constructs
against PPM1A: pSRG-shPPM1A494 (target sequence GGACTTG
AGACATGGTCAT), pSRG-shPPM1A881 (target sequence GCAG
GGGGCTCGGTGATGA), and pSRG-shmPPM1A494 (mouse target
sequence GGACTTGAATCGTGGTCAT). A new pSRG vector, modi-
fied to contain both H1 promoter- and U6 promoter-driven cassettes,
was used to simultaneously express shSmad2 (target sequence
GGATGAAGTATGTGTAAAC; Lin and Feng, 2005) and shSmad3 (tar-
get sequence GGATTGAGCTGCACCTGAATG; Jazag et al., 2005).
Cell Transfection, Immunoprecipitation, Western Blotting,
and Immunofluorescence
Cell culture, transfection, immunoprecipitation, Western blotting,
and immunofluorescence were performed essentially as described
(Feng et al., 2002; Lin et al., 2003). Antibodies against Smad2 and
P-Smad2 (Cell Signaling), Smad3 (Zymed), PPM1A (Abcam), and
others were used per manufacturers’ instructions. Anti-P-Smad3
(SXS) and anti-pS212 sera were kind gifts from Ed Leof (Mayo Clinic)
and Fang Liu (Rutgers), respectively.
Stable HaCaT cell lines with PPM1A knockdown were generated
by transfection with pSRG-shPPM1A494 or pSRG-shPPM1A881, se-
lected with puromycin (2 mg/ml), and verified by Western blotting and
real-time PCR analysis.
To establish tet-off expression of PPM1A, Mv1Lu-tTA cells (Reynis-
do´ttir et al., 1995) were stably transfected with pTRE2 vector (Clon-
tech) carrying Flag-PPM1A and a plasmid carrying a puromycin
marker. Stable clones were maintained in the presence of G418, puro-
mycin, and Dox (10 ng/ml) and switched to Dox-free medium to
achieve Flag-PPM1A expression.
In Vitro Protein Binding and Phosphatase Assays
Production of recombinant GST- and His-tagged proteins and in vitro
binding assays were previously described (Feng et al., 2002; Lin et al.,
2003; Supplemental Data). For comparing the binding of His-PPM1A
protein with phosphorylated versus unphosphorylated Smad2 MH2
(aa 241–467), 500 ng of Smad2 MH2 polypeptide was incubated
with His-PPM1A proteins immobilized on Ni-NTA agarose beads in a
buffer containing 20% glycerol, 20 mM HEPES (pH 7.9), 150 mM
KCl, 0.5 mM DTT, 0.2 mM EDTA, 0.2 mM EGTA, 0.2% NP-40,
60 mM imidazole, and 50 mM 1,6-hexanediol.
For phosphatase assays, recombinant PPM1A was incubated with
semisynthetic recombinant phospho-Smad2 MH2 (P-S2MH2), syn-
thesis of which was described previously (Wu et al., 2001). The phos-
phatase reaction was performed at 30ºC for 30 min in a buffer (7 mM
imidazole [pH 7.6], 20 mM magnesium acetate, 300 mg/ml bovine
serum albumin, 30 mM EDTA, and 0.03% b-mercaptoethanol) and
analyzed by anti-P-Smad2 Western blotting.
[3H]Thymidine Incorporation and PCNA Staining
Thymidine-incorporation-based DNA synthesis assay was performed
as previously described (Feng et al., 2002; Supplemental Data). For
PCNA staining, Mv1Lu-PPM1A cells (±Dox) were fixed, blocked, and
immunostained using a PCNA staining kit (Zymed).
Real-Time RT-PCR (qRT-PCR)
Total RNAs were prepared using TriZol reagent (Invitrogen) from
HaCaT or Mv1Lu cells treated with TGFb (2 ng/ml) for 0, 4, 8, and
24 hr. qRT-PCR was carried out using Assay-on-Demand kits or the
SYBR green method (ABI). mRNA levels of target genes were normal-
ized against 18S RNA. Each target was measured in triplicates. Data
were analyzed using Microsoft Excel.
Zebrafish Embryo Assay
Maintenance and manipulation of zebrafish embryos derived from the
Tu¨bingen strain, mRNA preparation, and in situ hybridization were car-
ried out as previously described (Zhang et al., 2004; Supplemental
Data).
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
1 table, and 23 figures and can be found with this article online at
http://www.cell.com/cgi/content/full/125/5/915/DC1/.
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